Testing effectiveness (Phase 2)Study completedNCT01270945
What this trial is testing
Safety and Preliminary Efficacy Study of an Anti-inflammatory Therapeutic Antibody in Reducing Restenosis.
Who this might be right for
Patients Undergoing Repeat Peripheral Artery Revascularization
Janssen Research & Development, LLC 43